학술논문
The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of ikaros and MYC signaling
Document Type
Article
Author
Source
In: Haematologica . (Haematologica, 30 September 2017, 102(10):1776-1784)
Subject
Language
English
ISSN
15928721
03906078
03906078